Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Capricor Therapeutics (CAPR) EPS (Basic): 2011-2024

Historic EPS (Basic) for Capricor Therapeutics (CAPR) over the last 14 years, with Dec 2024 value amounting to -$1.15.

  • Capricor Therapeutics' EPS (Basic) fell 42.11% to -$0.54 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.56, marking a year-over-year decrease of 52.94%. This contributed to the annual value of -$1.15 for FY2024, which is 38.55% down from last year.
  • As of FY2024, Capricor Therapeutics' EPS (Basic) stood at -$1.15, which was down 38.55% from -$0.83 recorded in FY2023.
  • In the past 5 years, Capricor Therapeutics' EPS (Basic) registered a high of -$0.83 during FY2023, and its lowest value of -$1.18 during FY2022.
  • Over the past 3 years, Capricor Therapeutics' median EPS (Basic) value was -$1.15 (recorded in 2024), while the average stood at -$1.05.
  • Per our database at Business Quant, Capricor Therapeutics' EPS (Basic) spiked by 57.28% in 2020 and then crashed by 38.55% in 2024.
  • Over the past 5 years, Capricor Therapeutics' EPS (Basic) (Yearly) stood at -$0.88 in 2020, then increased by 1.14% to -$0.87 in 2021, then crashed by 35.63% to -$1.18 in 2022, then increased by 29.66% to -$0.83 in 2023, then crashed by 38.55% to -$1.15 in 2024.